Cargando…

Association of Biomarker Levels with Severity of Asbestos-Related Diseases

OBJECTIVES: Asbestos-related diseases (ARDs) have increased globally over the decades, causing an economic burden and increased health care costs. It is difficult to predict the risk of development of ARDs and of respiratory disability among workers with a history of asbestos exposure. Blood based b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Eun-Kee, Yates, Deborah H, Creaney, Jenette, Thomas, Paul S, Robinson, Bruce W, Johnson, Anthony R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Occupational Safety and Health Research Institute 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430922/ https://www.ncbi.nlm.nih.gov/pubmed/22953226 http://dx.doi.org/10.5491/SHAW.2012.3.1.17

Ejemplares similares

Follow-up of Soluble Mesothelin-Related Protein Levels in Participants With Asbestos-Related Disorders
por: Park, Eun-Kee, et al.
Publicado: (2020)

Discovery of new biomarkers for malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2015)

Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma
por: Robinson, Cleo, et al.
Publicado: (2015)

ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
por: Morré, D. James, et al.
Publicado: (2016)

Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
por: Morré, D. James, et al.
Publicado: (2016)

Lung Function Profiles among Individuals with Nonmalignant Asbestos-related Disorders
por: Park, Eun-Kee, et al.
Publicado: (2014)

Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma
por: Sneddon, Sophie, et al.
Publicado: (2017)

How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies
por: Robinson, Bruce W.S., et al.
Publicado: (2022)

Auto-Antibodies to β-F1-ATPase and Vimentin in Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2011)

Clinical consequences of asbestos-related diffuse pleural thickening: A review
por: Miles, Susan E, et al.
Publicado: (2008)

What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
por: Redwood, Alec J., et al.
Publicado: (2022)

Characteristics of asbestos fibers in lung tissue from occupational and environmental asbestos exposure of lung cancer patients in Busan, Korea
por: Jung, Hyun-Sung, et al.
Publicado: (2020)

Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
por: Creaney, Jenette, et al.
Publicado: (2013)

Awareness of Asbestos and Action Plans for Its Exposure can Help Lives Exposed to Asbestos
por: Lee, Hu-Jang, et al.
Publicado: (2013)

Calretinin as a blood-based biomarker for mesothelioma
por: Johnen, Georg, et al.
Publicado: (2017)

Search for biomarkers of asbestos exposure and asbestos-induced cancers in investigations of the immunological effects of asbestos
por: Matsuzaki, Hidenori, et al.
Publicado: (2017)

Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo
por: Greening, David W., et al.
Publicado: (2016)

Asbestos exposure biomarkers in the follow-up of asbestos-exposed workers
por: PAOLUCCI, Valentina, et al.
Publicado: (2018)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome
por: Ma, Shaokang, et al.
Publicado: (2019)

Asbestos Exposure Level and the Carcinogenic Risk Due to Corrugated Asbestos-Cement Slate Roofs in Korea
por: Lee, Eun-Soo, et al.
Publicado: (2021)

The global health dimensions of asbestos and asbestos-related diseases
por: Ramazzini, Collegium
Publicado: (2016)

Asbestos: use, bans and disease burden in Europe
por: Kameda, Takashi, et al.
Publicado: (2014)

Compensation for Asbestos-Related Diseases in Japan: Utilization of Standard Classifications of Industry and Occupations
por: Sawanyawisuth, Kittisak, et al.
Publicado: (2017)

Prevention of Asbestos-Related Disease in Countries Currently Using Asbestos
por: Marsili, Daniela, et al.
Publicado: (2016)

Asbestos-related Disease
por: Al Jarad, Nabil
Publicado: (1999)

COLLEGIUM RAMAZZINIThe global health dimensions of asbestos and asbestos-related diseases
Publicado: (2016)

Asbestos
por: Diss, J P, et al.
Publicado: (1978)

Asbestos Exposure and Severity of COVID-19
por: Granados, Galo, et al.
Publicado: (2022)

Asbestos and Asbestos-related Diseases in Vietnam: In reference to the International Labor Organization/World Health Organization National Asbestos Profile
por: Pham, Van Hai, et al.
Publicado: (2013)

Prediction of Asbestos-Related Diseases (ARDs) and Chrysotile Asbestos Exposure Concentrations in Asbestos-Cement (AC) Manufacturing Factories in Zimbabwe
por: Mutetwa, Benjamin, et al.
Publicado: (2022)

Epidemiology of asbestos-related diseases.
por: Lemen, R A, et al.
Publicado: (1980)

Asbestos-related pleural disease
por: Geller, Stephen A., et al.
Publicado: (2013)

Development of the “National Asbestos Profile” to Eliminate Asbestos-Related Diseases in 195 Countries
por: Arachi, Diana, et al.
Publicado: (2021)

Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma
por: Fan, Xiyong, et al.
Publicado: (2019)

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
por: Chee, Jonathan, et al.
Publicado: (2018)

Trace element levels in pleural effusions
por: Fitzgerald, Deirdre B., et al.
Publicado: (2021)

Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases
por: Ying, Shibo, et al.
Publicado: (2017)

Cumulative asbestos exposure and mortality from asbestos related diseases in a pooled analysis of 21 asbestos cement cohorts in Italy
por: Luberto, Ferdinando, et al.
Publicado: (2019)

Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies
por: Li, Shamin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ojfup986usoa032rv0eqacqtv